DJIA 17,841.98 -86.22 -0.48%
NASDAQ 4,919.64 -19.68 -0.40%
S&P 500 2,080.15 -9.31 -0.45%
market minute promo

Celgene (NASDAQ: CELG)

108.65 1.11 (1.03%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $108.65 1.03%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $108.49
Previous Close $107.54
Daily Range $106.45 - $108.99
52-Week Range $71.32 - $129.06
Market Cap $86.2B
P/E Ratio 36.83
Dividend (Yield) $0.00 (0.0%)
Volume 5,566,251
Average Daily Volume 5,952,459
Current FY EPS $4.07

Sector

Healthcare

Industry

Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary Rss Feed

bluebird bio Plans to Sing in June

During its first-quarter earnings release, bluebird bio discloses plans to present data at the European Hematology Association meeting in June.

The Zacks Analyst Blog Highlights: Celgene, Laboratory Corp. of America Holdings, Quest Diagnostics

The Zacks Analyst Blog Highlights: Celgene, Laboratory Corp. of America Holdings, Quest Diagnostics and Ensign Group - Press Releases

Celgene's Earnings Shine While Revenue Misses By An Inch In The First Quarter

3 Stocks Raising The Drugs Industry Higher

Celgene Breaks Below 200-Day Moving Average - Notable for CELG

Huge Buyout Highlights 4 Deutsche Bank Biotech Focus Stocks

Goldman Sachs Reviews Biotech: Amgen, Celgene And Clovis Oncology

Will Agios (AGIO) Disappoint this Earnings Season? - Analyst Blog

Frothy China Or No, World Mutual Funds Topped In April

Excitement Should Build At Sorrento Therapeutics

See More CELG News...

CELG's Top Competitors

CELG $108.65 (1.03%)
Current stock: CELG
AMGN $158.96 (-0.30%)
Current stock: AMGN
GILD $102.27 (-0.70%)
Current stock: GILD
$0.00 (0.00%)
Current stock: